MICHELE SHOOK: Open Payments
NPI 1841296563 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,540 in 62 payments from 27 companies in 2025. Trend: 2023 $363 · 2024 $798 · 2025 $1,540
Food & beverage: $1,540
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $170 |
| AstraZeneca Pharmaceuticals LP | 7 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $159 |
| BeOne Medicines USA, Inc. | 4 | $88 |
| Incyte Corporation | 4 | $75 |
| Genentech USA, Inc. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| GENZYME CORPORATION | 2 | $61 |
| Janssen Biotech, Inc. | 2 | $60 |
| TerSera Therapeutics LLC | 2 | $56 |
Products named: KEYTRUDA, ENHERTU, Venclexta, NINLARO, BRUKINSA, Zoladex, Nubeqa, KISQALI.
Industry payments across GA — which companies pay providers there.
